Business:
GPCR Drug Discovery
Drug notes:
Undisclosed Clin0 Grave's disease, thyroid eye disease; 3 CNS disorders, inflammatory & pain disorders, undisclosed
About:
Septerna is developing drugs against G-protein coupled receptors (GPCRs). GPCRs are found at the cell membrane and have proven to be the most ‘druggable’ class of proteins. However, many remain ‘undruggable’. Septerna is addressing this problem using their Native Complex platform to design a new era of GPCR-targeted medicines. The platform recapitulates the native structure, function and dynamics of GPCRs, thus enabling structure-based drug design and large-scale screening. Drug hits are further examined with Cryo-EM and optimized through in silico approaches. Due to the prolific nature of GPCRs, Septerna’s diversified portfolio spans multiple therapeutic areas.
VP, Intellectual Property and Corporate Legal South San Francisco, California, United States|5 days ago
Senior Manager/Associate Director, Non-Clinical St... South San Francisco, California, United States|23 days ago
Director, DMPK South San Francisco, California, United States|38 days ago
Senior Staff Scientist, Computational Chemistry South San Francisco, California, United States|40 days ago
Director/Senior Director, Disease Biology (Cell Bi... South San Francisco, California, United States|59 days ago
Senior Medical Director, Clinical Development South San Francisco, California, United States|100+ days ago